Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways

Xuhao Ni; Yongxiang Xia; Shun Zhou; Hao Peng; Xiao Wu; Hao Lu; Han Wang; Rui Liu; Bruce R. Blazar; Jian Gu; Ling Lu

doi:10.1038/s41419-018-1273-7

Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways

Xuhao Ni, Yongxiang Xia, Shun Zhou, Hao Peng, Xiao Wu, Hao Lu, Han Wang, Rui Liu, Bruce R. Blazar, Jian Gu, Ling Lu

Health Sciences Administration

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Human gingival tissue-derived mesenchymal stem cells (GMSCs) present an accessible source of mesenchymal stem cells (MSCs) for treating autoimmune diseases. Here we show that human GMSCs can prevent and treat acute graft-versus-host disease (GVHD) in two different mouse models. Our results indicate that besides exhibiting suppressive function in vitro and in vivo, GMSCs may also regulate the conversion of Tregs to Th1 and/or Th17-like cells, as well as stabilize Foxp3 expression. Furthermore, GMSC-mediated prevention of acute GVHD was dependent on CD39 signaling that play an important role in the function and stability of Tregs. Finally, we also observed stronger protective ability of GMSCs with greater expansion ability compared with BMSCs or ASCs. These results indicate that human GMSCs have the potential to be used to treat GVHD.

Original language	English (US)
Article number	13
Journal	Cell Death and Disease
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41419-018-1273-7
State	Published - Jan 1 2019

Bibliographical note

Funding Information:
This work was supported by the National 863 project (NO. 2015AA020932), Natural Science Foundation of China (No. 81100270), Natural Science Foundation of China (No. 81571557), the Natural Science Foundation of Jiangsu (No. BK20131024) and International cooperation project of Jiangsu Province (No. BZ2011041).

Publisher Copyright:
© 2019, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/s41419-018-1273-7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325106

Find It

Find It at U of M Libraries

Cite this

@article{35beb16213a6462192ec5a17e9176b4e,

title = "Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways",

abstract = "Human gingival tissue-derived mesenchymal stem cells (GMSCs) present an accessible source of mesenchymal stem cells (MSCs) for treating autoimmune diseases. Here we show that human GMSCs can prevent and treat acute graft-versus-host disease (GVHD) in two different mouse models. Our results indicate that besides exhibiting suppressive function in vitro and in vivo, GMSCs may also regulate the conversion of Tregs to Th1 and/or Th17-like cells, as well as stabilize Foxp3 expression. Furthermore, GMSC-mediated prevention of acute GVHD was dependent on CD39 signaling that play an important role in the function and stability of Tregs. Finally, we also observed stronger protective ability of GMSCs with greater expansion ability compared with BMSCs or ASCs. These results indicate that human GMSCs have the potential to be used to treat GVHD.",

author = "Xuhao Ni and Yongxiang Xia and Shun Zhou and Hao Peng and Xiao Wu and Hao Lu and Han Wang and Rui Liu and Blazar, {Bruce R.} and Jian Gu and Ling Lu",

note = "Funding Information: This work was supported by the National 863 project (NO. 2015AA020932), Natural Science Foundation of China (No. 81100270), Natural Science Foundation of China (No. 81571557), the Natural Science Foundation of Jiangsu (No. BK20131024) and International cooperation project of Jiangsu Province (No. BZ2011041). Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41419-018-1273-7",

language = "English (US)",

volume = "10",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways

AU - Ni, Xuhao

AU - Xia, Yongxiang

AU - Zhou, Shun

AU - Peng, Hao

AU - Wu, Xiao

AU - Lu, Hao

AU - Wang, Han

AU - Liu, Rui

AU - Blazar, Bruce R.

AU - Gu, Jian

AU - Lu, Ling

N1 - Funding Information: This work was supported by the National 863 project (NO. 2015AA020932), Natural Science Foundation of China (No. 81100270), Natural Science Foundation of China (No. 81571557), the Natural Science Foundation of Jiangsu (No. BK20131024) and International cooperation project of Jiangsu Province (No. BZ2011041). Publisher Copyright: © 2019, The Author(s).

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Human gingival tissue-derived mesenchymal stem cells (GMSCs) present an accessible source of mesenchymal stem cells (MSCs) for treating autoimmune diseases. Here we show that human GMSCs can prevent and treat acute graft-versus-host disease (GVHD) in two different mouse models. Our results indicate that besides exhibiting suppressive function in vitro and in vivo, GMSCs may also regulate the conversion of Tregs to Th1 and/or Th17-like cells, as well as stabilize Foxp3 expression. Furthermore, GMSC-mediated prevention of acute GVHD was dependent on CD39 signaling that play an important role in the function and stability of Tregs. Finally, we also observed stronger protective ability of GMSCs with greater expansion ability compared with BMSCs or ASCs. These results indicate that human GMSCs have the potential to be used to treat GVHD.

AB - Human gingival tissue-derived mesenchymal stem cells (GMSCs) present an accessible source of mesenchymal stem cells (MSCs) for treating autoimmune diseases. Here we show that human GMSCs can prevent and treat acute graft-versus-host disease (GVHD) in two different mouse models. Our results indicate that besides exhibiting suppressive function in vitro and in vivo, GMSCs may also regulate the conversion of Tregs to Th1 and/or Th17-like cells, as well as stabilize Foxp3 expression. Furthermore, GMSC-mediated prevention of acute GVHD was dependent on CD39 signaling that play an important role in the function and stability of Tregs. Finally, we also observed stronger protective ability of GMSCs with greater expansion ability compared with BMSCs or ASCs. These results indicate that human GMSCs have the potential to be used to treat GVHD.

UR - http://www.scopus.com/inward/record.url?scp=85059764829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059764829&partnerID=8YFLogxK

U2 - 10.1038/s41419-018-1273-7

DO - 10.1038/s41419-018-1273-7

M3 - Article

C2 - 30622237

AN - SCOPUS:85059764829

SN - 2041-4889

VL - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 1

M1 - 13

ER -

Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this